BRUNETTI, Lorenzo
 Distribuzione geografica
Continente #
NA - Nord America 931
EU - Europa 806
AS - Asia 85
AF - Africa 1
Totale 1.823
Nazione #
US - Stati Uniti d'America 931
RU - Federazione Russa 550
IE - Irlanda 104
SE - Svezia 76
SG - Singapore 36
IN - India 32
GB - Regno Unito 30
IT - Italia 27
CN - Cina 12
BE - Belgio 8
FI - Finlandia 5
DE - Germania 4
KR - Corea 4
CI - Costa d'Avorio 1
FR - Francia 1
GR - Grecia 1
IL - Israele 1
Totale 1.823
Città #
Chandler 338
Dublin 98
Ashburn 77
Fairfield 48
Lawrence 35
Princeton 35
Boardman 32
Pune 32
Wilmington 30
Cambridge 16
London 16
Los Angeles 15
Des Moines 14
Bologna 10
Washington 10
Woodbridge 10
San Diego 9
Brussels 8
Haikou 8
Houston 7
Seattle 7
New York 6
Helsinki 5
Ann Arbor 4
Acton 3
Prescot 3
Ancona 2
Hounslow 2
Kilburn 2
Seoul 2
Verona 2
Yuseong-gu 2
Abidjan 1
Atlanta 1
Buffalo 1
Islington 1
Norwalk 1
Nuremberg 1
Perugia 1
Redmond 1
San Mateo 1
Sesto Fiorentino 1
Shanghai 1
Singapore 1
Southwark 1
Tel Aviv 1
Thessaloniki 1
Wandsworth 1
Totale 904
Nome #
Highly efficient gene disruption of murine and human hematopoietic progenitor cells by CRISPR/Cas9 579
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells 72
Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics 58
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 48
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9 45
How I diagnose and treat NPM1-mutated AML 43
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression 40
DNMT3A in Leukemia 38
CD123 is consistently expressed on NPM1-mutated AML cells 38
Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception 36
NPM1-mutated acute myeloid leukemia: From bench to bedside 34
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice 34
Actinomycin d targets npm1c-primed mitochondria to restore pml-driven senescence in aml therapy 34
It's All About MEis: Menin-MLL Inhibition Eradicates NPM1-Mutated and MLL-Rearranged Acute Leukemias in Mice 33
Nutrient-sensitive transcription factors TFEB and TFE3 couple autophagy and metabolism to the peripheral clock 33
Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field 32
CD200/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells: Correspondence 32
Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice 32
Response to: “Cytoplasmic dislocation of NPM1 and PU.1 in NPM1-mutated leukemia is obscured by paraformaldehyde fixation” 31
Aerobic Plus Resistance Exercise in Obese Older Adults Improves Muscle Protein Synthesis and Preserves Myocellular Quality Despite Weight Loss 30
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells 30
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome 30
PU.1 subcellular localization in acute myeloid leukaemia with mutated NPM1 29
TFEB regulates murine liver cell fate during development and regeneration 28
The absent/low expression of CD34 in NPM1-mutated AML is not related to cytoplasmic dislocation of NPM1 mutant protein 27
Dactinomycin in NPM1-Mutated acute myeloid leukemia 27
null 27
Effect of the COVID-19 pandemic on laboratory and clinical research: A testimony and a call to action from researchers 27
Loss of Capicua alters early T cell development and predisposes mice to T cell lymphoblastic leukemia/lymphoma 26
Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities 24
Systematic profiling of DNMT3A variants reveals protein instability mediated by the DCAF8 E3 ubiquitin ligase adaptor 24
NOVEL NPM1 EXON 5 MUTATIONS AND GENE FUSIONS LEADING TO ABERRANT CYTOPLASMIC NUCLEOPHOSMIN IN AML 24
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: A shared clonal origin 23
AML-099 Prolonged XPO1 Inhibition Is Essential for Optimal Anti-Leukemic Activity in NPM1-Mutated AML 22
Tissue-Biased Expansion of DNMT3A-Mutant Clones in a Mosaic Individual Is Associated with Conserved Epigenetic Erosion 22
New insights into the biology of acute myeloid leukemia with mutated NPM1 21
Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells 21
Mutant NPM1 Maintains the Leukemic State through HOX Expression 19
Mutant NPM1 directly regulates oncogenic transcription in acute myeloid leukemia 17
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 17
Current status and future perspectives in targeted therapy of NPM1-mutated AML 17
DNMT3A-coordinated splicing governs the stem state switch towards differentiation in embryonic and haematopoietic stem cells 16
Mutant NPM1: Nuclear export and the mechanism of leukemogenesis 12
NPM1-mutated AML with starry sky pattern 12
Overlapping features of therapy-related and de novoNPM1-mutated AML 9
The NPM1 mutant defines AML irrespective of blast count 3
DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A 2
An atypical GABARAP binding module drives the pro-autophagic potential of the AML-associated NPM1c variant 1
Totale 1.879
Categoria #
all - tutte 13.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 3 0
2021/2022288 0 18 0 0 53 48 1 11 49 8 22 78
2022/2023689 67 80 49 77 49 64 6 57 171 2 29 38
2023/2024899 80 15 37 50 48 205 130 132 77 98 27 0
Totale 1.879